Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/22955
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSumpter, JP-
dc.contributor.authorRunnalls, TJ-
dc.contributor.authorDonnachie, RL-
dc.contributor.authorOwen, SF-
dc.date.accessioned2021-07-19T05:34:53Z-
dc.date.available2021-11-01-
dc.date.available2021-07-19T05:34:53Z-
dc.date.issued2021-06-23-
dc.identifier.citationSumpter JP, Runnalls TJ, Donnachie RL, Owen SF. A comprehensive aquatic risk assessment of the beta-blocker propranolol, based on the results of over 600 research papers. Science of The Total Environment. 2021 Jun 23:148617.en_US
dc.identifier.issn0048-9697-
dc.identifier.issn1879-1026-
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/22955-
dc.description.abstractA comprehensive aquatic environmental risk assessment (ERA) of the human pharmaceutical propranolol was conducted, based on all available scientific literature. Over 200 papers provided information on environmental concentrations (77 of which provided river concentrations) and 98 dealt with potential environmental effects. The median concentration of propranolol in rivers was 7.1 ng/L (range of median values of individual studies 0.07 to 89 ng/L), and the highest individual value was 590 ng/L. Sixty-eight EC50 values for 35 species were available. The lowest EC50 value was 0.084 mg/L. A species sensitivity distribution (SSD) provided an HC50 value of 6.64 mg/L and an HC5 value of 0.22 mg/L. Thus, there was a difference of nearly 6 orders of magnitude between the median river concentration and the HC50 value, and over 4 orders of magnitude between the median river concentration and the HC5 value. Even if an assessment factor of 100 was applied to the HC5 value, to provide considerable protection to all species, the safety margin is over 100-fold. However, nearly half of all papers reporting effects of propranolol did not provide an EC50 value. Some reported that very low concentrations of propranolol caused effects. The lowest concentration reported to cause an effect - in fact, a range of biochemical and physiological effects on mussels - was 0.3 ng/L. In none of these ‘low concentration’ papers was a sigmoidal concentration-response relationship obtained. Although inclusion of data from these papers in the ERA cause a change in the conclusion reached, we are sceptical of the repeatability of these ‘low concentration’ results. We conclude that concentrations of propranolol present currently in rivers throughout the world do not constitute a risk to aquatic organisms. We discuss the need to improve the quality of ecotoxicology research so that more robust ERAs acceptable to all stakeholders can be completed.en_US
dc.description.sponsorshipAstraZeneca; Natural Environment Research Councilen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectPharmaceuticals in the environmenten_US
dc.subjectPropranololen_US
dc.subjectEnvironmental risk assessmenten_US
dc.subjectEnvironmental concentrationsen_US
dc.subjectRepeatabilityen_US
dc.titleA comprehensive aquatic risk assessment of the beta-blocker propranolol, based on the results of over 600 research papersen_US
dc.typeArticleen_US
dc.identifier.doihttp://dx.doi.org/10.1016/j.scitotenv.2021.148617-
dc.relation.isPartOfScience of the Total Environment-
pubs.publication-statusAccepted-
pubs.volume793-
dc.identifier.eissn1879-1026-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdf1.51 MBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.